Publication
Article
BioPharm International
BioPharm International-10-15-2015Volume2015 eBook Issue 2
Aseptic Processing for Cytotherapy, Regenerative Medicine, and Tissue-Engineered Products
Author(s):
Isolators offer a safety and economic advantage for next-generation regenerative medicine products.
BioPharm International
eBooks Volume 28, Issue 14
Manufacturing advanced biologics demands solutions that are quite different from what is being used for large-scale industrial biologics processing today. This article touches on approaches that work with advanced biologics. Read this article and other articles in
BioPharm International
's 2015
The Future of BioprocessingeBook.
Articles in this issue
Fluctuating Capacity and Demand Conditions in Biomanufacturing
Cleaning Validation for Biologics
Automation of Single-Use Systems
Aseptic Processing for Cytotherapy, Regenerative Medicine, and Tissue-Engineered Products
Are Biopharma Patents Poised on the Post-Grant Chopping Block?
Innovations in Automation—High-Throughput Dynamic Light Scattering for Screening Biotherapeutic Formulations
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Videos
Related Content
